These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Biopharmaceutical study of insulin suppositories. Mesiha MS; Lobel S; Salo DP; Khaleeva LD; Zekova NY Pharmazie; 1981; 36(1):29-32. PubMed ID: 7012849 [TBL] [Abstract][Full Text] [Related]
5. Rh/IGF-I/rhIGFBP-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucose. Clemmons DR; Moses AC; Sommer A; Jacobson W; Rogol AD; Sleevi MR; Allan G Growth Horm IGF Res; 2005 Aug; 15(4):265-74. PubMed ID: 16005252 [TBL] [Abstract][Full Text] [Related]
6. The rabbit as an experimental model for biopharmaceutical studies following rectal administration of theophylline. Van Aerde P; Moerman E; Van Severen R; Braeckman P Pharmazie; 1984 Mar; 39(3):171-2. PubMed ID: 6728890 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories. Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614 [TBL] [Abstract][Full Text] [Related]
8. A lecithin-based microemulsion of rh-insulin with aprotinin for oral administration: Investigation of hypoglycemic effects in non-diabetic and STZ-induced diabetic rats. Cilek A; Celebi N; Tirnaksiz F; Tay A Int J Pharm; 2005 Jul; 298(1):176-85. PubMed ID: 15950411 [TBL] [Abstract][Full Text] [Related]
9. Beta-cell function and mass in type 2 diabetes. Larsen MO Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971 [TBL] [Abstract][Full Text] [Related]
10. Comparison of pharmacokinetic and pharmacodynamic properties of single-dose oral insulin spray and subcutaneous insulin injection in healthy subjects using the euglycemic clamp technique. Cernea S; Kidron M; Wohlgelernter J; Modi P; Raz I Clin Ther; 2004 Dec; 26(12):2084-91. PubMed ID: 15823772 [TBL] [Abstract][Full Text] [Related]
11. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion. Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098 [TBL] [Abstract][Full Text] [Related]
12. Insulin glargine has a long duration of effect following administration either once daily or twice daily in divided doses in healthy cats. Marshall RD; Rand JS; Morton JM J Feline Med Surg; 2008 Oct; 10(5):488-94. PubMed ID: 18703367 [TBL] [Abstract][Full Text] [Related]
13. Biopharmaceutic aspects of buccal absorption of insulin. Oh CK; Ritschel WA Methods Find Exp Clin Pharmacol; 1990 Apr; 12(3):205-12. PubMed ID: 2191174 [TBL] [Abstract][Full Text] [Related]
14. The effect of rectal administration of insulin on the short-term treatment of alloxan-diabetic dogs. Yamasaki Y; Shichiri M; Kawamori R; Morishima T; Hakui N; Yagi T; Abe H Can J Physiol Pharmacol; 1981 Jan; 59(1):1-6. PubMed ID: 7011508 [TBL] [Abstract][Full Text] [Related]
15. Inhalation of human insulin is associated with improved insulin action compared with subcutaneous injection and endogenous secretion in dogs. Edgerton DS; Stettler KM; Neal DW; Scott M; Bowen L; Wilson W; Hobbs CH; Leach C; Strack TR; Cherrington AD J Pharmacol Exp Ther; 2006 Dec; 319(3):1258-64. PubMed ID: 16963622 [TBL] [Abstract][Full Text] [Related]
16. Intramuscular versus subcutaneous injection of soluble and lispro insulin: comparison of metabolic effects in healthy subjects. Rave K; Heise T; Weyer C; Herrnberger J; Bender R; Hirschberger S; Heinemann L Diabet Med; 1998 Sep; 15(9):747-51. PubMed ID: 9737803 [TBL] [Abstract][Full Text] [Related]
17. Investigation of physical and hypoglycaemic properties of rectal suppositories with chosen insulin. Kosior A Acta Pol Pharm; 2002; 59(5):353-8. PubMed ID: 12602796 [TBL] [Abstract][Full Text] [Related]
18. Inhaled human insulin: new drug. No short-term advantages, too many unknowns in the long term. Prescrire Int; 2006 Dec; 15(86):203-9. PubMed ID: 17165235 [TBL] [Abstract][Full Text] [Related]
19. Insulin detemir under steady-state conditions: no accumulation and constant metabolic effect over time with twice daily administration in subjects with Type 1 diabetes. Bott S; Tusek C; Jacobsen LV; Endahl L; Draeger E; Kapitza C; Heise T Diabet Med; 2006 May; 23(5):522-8. PubMed ID: 16681561 [TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 beta induced transient diabetes mellitus in rats. A model of the initial events in the pathogenesis of insulin-dependent diabetes mellitus? Reimers JI Dan Med Bull; 1998 Apr; 45(2):157-80. PubMed ID: 9587701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]